BIOMAT Database Logo BIOMAT Database Logo

The clinical pharmacology of dihydroergotoxine mesylate (Hydergine). 1985

I M James

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I M James
Effect of dihydroergotoxine mesylate (Hydergine) on delayed neuronal death in the gerbil hippocampus.
September 1988, Acta neurologica Scandinavica,
I M James
A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
March 1987, Journal of the American Geriatrics Society,
I M James
Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).
January 1980, Advances in biochemical psychopharmacology,
I M James
Effects of dihydroergotoxine (hydergine) on peripheral blood alcohol levels.
January 1980, Life sciences,
I M James
[Dihydroergotoxine mesylate in the treatment of functioning pituitary adenoma].
February 1989, Neurologia medico-chirurgica,
I M James
Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
February 1987, Transplantation proceedings,
I M James
Dihydroergotoxine(Hydergine) and ethanol-induced aging of C57BL/6J male mice.
January 1978, Pharmacology,
I M James
Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease.
January 2019, Parkinsonism & related disorders,
I M James
Co-dergocrine mesylate (Hydergine) and hypertensive emergencies.
January 1989, Nephron,
I M James
Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations.
December 1987, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!